Cookson Peirce & Co’s 10x Genomics TXG Stock Holding History

Cookson Peirce & Co’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Buy	80,312 +50,312	+168%	+$1.32M	0.1%	95
2026 Q1	$637K	Sell	30,000 -5,000	-14%	-$100K	0.03%	220
2025 Q4	$571K	Buy	+35,000	New	+$529K	0.02%	231
2025 Q3	–	Sell	-25,000	Closed	-$290K	–	351
2025 Q2	$290K	Buy	+25,000	New	+$228K	0.01%	244
2021 Q2	–	Sell	-17,835	Closed	-$3.23M	–	234
2021 Q1	$3.23M	Buy	+17,835	New	+$3.08M	0.21%	71

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Cookson Peirce & Co's TXG Position: Q2 2026 in Review

Cookson Peirce & Co increased its 10x Genomics (TXG) stake by 168% in Q2 2026, buying an estimated $1.32M and bringing the position to 80,312 shares worth $3.08M. The position accounts for 0.1% of the portfolio, ranked #95.

Cookson Peirce & Co first reported a position in TXG in Q1 2021 and has held it in 5 quarters since. The position peaked at $3.23M in Q1 2021. 60 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Cookson Peirce & Co held 80,312 shares of 10x Genomics worth $3.08M as of Q2 2026.
Cookson Peirce & Co bought 50,312 10x Genomics shares in Q2 2026, an estimated $1.32M.
10x Genomics made up 0.1% of Cookson Peirce & Co's portfolio in Q2 2026, its #95 holding.
Cookson Peirce & Co first reported a position in 10x Genomics in Q1 2021 and has held it in 5 quarters since.
Cookson Peirce & Co's 10x Genomics position peaked at $3.23M in Q1 2021.
60 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.